Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins
Description
Nanobodies bind a target antigen with a kinetic profile similar to a conventional antibody, but exist as a single heavy chain domain that can be readily multimerized to engage antigen via multiple interactions. Presently, most nanobodies are produced
